ICOSLG and graft versus host disease: To examine the effects of the ICOSL vIgD-Fc in a more prolonged inflammation model, the same ICOSL vIgD-Fc proteins plus an additional variant, A184, were tested in a huPBMC-NSGTM model of graft-versus-host disease (GvHD).